Pawar Yuga, Daigavane Sachin, Thool Archana R, Swaminathan Uma, Javed Zoya
Ophthalmology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus. 2024 Aug 5;16(8):e66152. doi: 10.7759/cureus.66152. eCollection 2024 Aug.
One of the primary reasons for discernible or complete loss of sight in middle-aged and older persons is central retinal vein occlusion (CRVO). Three intravitreal bevacizumab (Avastin) injections were administered to a 39-year-old male patient as part of his therapy for his prior diabetic retinopathy due to uncontrolled diabetes. The patient was advised to undergo gonioscopy and an undilated iris examination to look for angle neovascularization during the next three months of follow-up. We demonstrated an extraordinary instance of unilateral ischemia CRVO (macular edema), where the main cause of risk was insulin resistance. To avoid a situation like this, close observation and diabetes management are recommended.
中老年人群视力明显下降或完全失明的主要原因之一是视网膜中央静脉阻塞(CRVO)。一名39岁男性患者因糖尿病控制不佳导致先前患有糖尿病性视网膜病变,作为其治疗的一部分接受了三次玻璃体内注射贝伐单抗(阿瓦斯汀)。建议该患者在接下来的三个月随访期间接受前房角镜检查和未散瞳的虹膜检查,以寻找房角新生血管。我们展示了一个单侧缺血性CRVO(黄斑水肿)的特殊病例,其中主要风险因素是胰岛素抵抗。为避免出现这种情况,建议密切观察并进行糖尿病管理。